Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: a single-blinded prospective mono-center study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS One, volume 12, issue 10, e0186720 (2017)
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2017
- Urheber
-
Friedrich-Rust, Mireen
Schölzel, Fabian
Maier, Sebastian
Seeger, Florian
Rey, Julia
Fichtlscherer, Stephan
Herrmann, Eva
Zeuzem, Stefan
Bojunga, Jörg
- URN
-
urn:nbn:de:hebis:30:3-438070
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Friedrich-Rust, Mireen
- Schölzel, Fabian
- Maier, Sebastian
- Seeger, Florian
- Rey, Julia
- Fichtlscherer, Stephan
- Herrmann, Eva
- Zeuzem, Stefan
- Bojunga, Jörg
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2017
Ähnliche Objekte (12)
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease
Assessment of Alcohol Consumption in Outpatients with Non-alcoholic Fatty Liver Disease
Impact of heterofermentative lactobacilli on development of non-alcoholic fatty liver disease
The relationship between the dietary omega- 6/omega-3 ratio, gut microbiota composition and disease severity in patients with non-alcoholic fatty liver disease
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease
Assessment of Alcohol Consumption in Outpatients with Non-alcoholic Fatty Liver Disease
Impact of heterofermentative lactobacilli on development of non-alcoholic fatty liver disease
The relationship between the dietary omega- 6/omega-3 ratio, gut microbiota composition and disease severity in patients with non-alcoholic fatty liver disease
Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease
Assessment of Alcohol Consumption in Outpatients with Non-alcoholic Fatty Liver Disease
Impact of heterofermentative lactobacilli on development of non-alcoholic fatty liver disease